Valuation: Viatris Inc.

Market Cap 19.45B 17B 15.62B 14.56B 27.62B 1,852B 28.04B 188B 72.92B 910B 73B 71.43B 3,137B P/E 2026 *
61.1x
P/E 2027 * 26.4x
Enterprise Value 31.63B 27.66B 25.42B 23.69B 44.93B 3,012B 45.61B 305B 119B 1,481B 119B 116B 5,102B EV / Sales 2026 *
2.14x
EV / Sales 2027 * 2.03x
Free-Float
92.23%
Yield 2026 *
3.05%
Yield 2027 * 3.13%
1 day+3.21%
1 week+3.92%
Current month+5.16%
1 month+6.44%
3 months+24.26%
6 months+34.03%
Current year+34.14%
1 week 15.8
Extreme 15.795
16.74
1 month 14.94
Extreme 14.94
16.74
Current year 12.19
Extreme 12.19
17.53
1 year 8.62
Extreme 8.625
17.53
3 years 6.85
Extreme 6.85
17.53
5 years 6.85
Extreme 6.85
17.53
10 years 6.85
Extreme 6.85
50.4
Manager TitleAgeSince
Chief Executive Officer 63 2023-03-31
Director of Finance/CFO 59 2026-05-07
Chief Tech/Sci/R&D Officer - 2023-12-14
Director TitleAgeSince
Director/Board Member 78 2020-11-15
Director/Board Member 78 2020-11-15
Director/Board Member 62 2020-11-15
Date Insider Type Main position Quantity % Market Cap.
06-29Free

Director

2,756 0.0002%
06-29Free

Director

2,362 0.0002%
06-24Sell

Chief Financial Officer

-50,076 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%+3.92%+78.80%+67.33% 19.45B
+3.45%+7.65%+55.77%+158.84% 1,082B
-1.16%+7.42%+69.09%+58.92% 633B
-0.77%+7.37%+36.87%+93.77% 461B
-0.35%+1.85%+31.30%+24.86% 339B
-0.56%+1.17%+41.96%+39.64% 301B
-0.08%+1.49%+32.40%+44.75% 292B
-1.54%+2.58%-25.52%-39.75% 225B
+3.55%+6.05%+26.04%+68.52% 202B
+0.40%+6.00%+17.72%+70.33% 163B
Average +1.66%+2.30%+36.44%+58.72% 371.92B
Weighted average by Cap. +1.38%+1.96%+42.43%+81.64%

Financials

2026 *2027 *
Net sales 14.77B 12.92B 11.87B 11.06B 20.98B 1,407B 21.3B 142B 55.39B 691B 55.46B 54.27B 2,383B 15.04B 13.15B 12.08B 11.26B 21.36B 1,432B 21.68B 145B 56.38B 704B 56.45B 55.23B 2,425B
Net income 13M 11.36M 10.44M 9.73M 18.46M 1.24B 18.74M 125M 48.73M 608M 48.79M 47.74M 2.1B 498M 435M 400M 373M 707M 47.37B 717M 4.8B 1.87B 23.29B 1.87B 1.83B 80.24B
Net Debt 12.19B 10.65B 9.79B 9.13B 17.31B 1,160B 17.57B 118B 45.69B 570B 45.74B 44.76B 1,965B 11.03B 9.64B 8.86B 8.26B 15.67B 1,050B 15.9B 106B 41.36B 516B 41.4B 40.52B 1,779B
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.
Employees
30,000
Date Price Change Volume
26-07-02 US$16.70 +3.21% 9,042,025
26-07-01 US$16.18 +1.89% 13,488,471
26-06-30 US$15.88 -2.16% 10,545,203
26-06-29 US$16.23 -0.61% 8,986,925
26-06-26 US$16.33 +1.62% 12,849,203
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
16.70USD
Average target price
17.81USD
Spread / Average Target
+6.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VTRS Stock